Business United States United States
Lilly to Buy Merida for $2.88 Billion in Autoimmune Push
Eli Lilly & Co. plans to buy Merida Biosciences Inc. for as much as $2.88 billion in cash to expand in autoimmune and allergic diseases, part of an e…
Bloomberg Bloomberg 1h ago